HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
John J Kavanagh Selected Research
John J Kavanagh Research Topics
Disease
28
Neoplasms (Cancer)
11/2020 - 03/2002
19
Ovarian Neoplasms (Ovarian Cancer)
11/2020 - 03/2002
8
Ovarian Epithelial Carcinoma
11/2020 - 01/2003
7
Carcinoma (Carcinomatosis)
09/2012 - 12/2002
5
Carcinogenesis
10/2009 - 01/2005
4
Disease Progression
06/2012 - 05/2006
3
Mesothelioma
11/2003 - 03/2002
2
Neutropenia
11/2020 - 04/2006
2
Anemia
11/2020 - 10/2002
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2014 - 09/2008
2
Neoplasm Metastasis (Metastasis)
01/2014 - 06/2005
2
Endometrial Neoplasms (Endometrial Cancer)
01/2008 - 11/2004
2
Thrombocytopenia (Thrombopenia)
10/2002 - 06/2002
1
Abdominal Pain (Pain, Abdominal)
11/2020
1
Constipation
11/2020
1
Diarrhea
11/2020
1
Fallopian Tube Neoplasms
11/2020
1
Sarcoma (Soft Tissue Sarcoma)
01/2013
1
Chronic Renal Insufficiency
08/2007
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2006
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2006
1
Cystadenoma
05/2006
1
Exanthema (Rash)
04/2006
1
Edema (Dropsy)
04/2006
1
Inflammation (Inflammations)
06/2005
1
Thrombosis (Thrombus)
06/2005
Drug/Important Bio-Agent (IBA)
14
Platinum
IBA
11/2020 - 06/2002
6
Proteins (Proteins, Gene)
FDA Link
05/2006 - 12/2002
5
Aurora Kinases
IBA
01/2018 - 02/2006
5
taxane
IBA
07/2012 - 01/2004
4
Topotecan (Hycamtin)
FDA Link
Generic
11/2020 - 01/2004
4
Cisplatin (Platino)
FDA Link
Generic
01/2014 - 06/2002
4
Carboplatin (JM8)
FDA Link
Generic
09/2012 - 06/2002
4
Pharmaceutical Preparations
IBA
11/2008 - 12/2004
3
Biomarkers (Surrogate Marker)
IBA
07/2012 - 01/2004
3
Biological Products
IBA
07/2010 - 02/2003
2
Valproic Acid (Depakote)
FDA Link
Generic
01/2018 - 01/2013
2
Histones (Histone)
IBA
01/2013 - 09/2012
2
Docetaxel (Taxotere)
FDA Link
07/2012 - 06/2002
2
DNA (Deoxyribonucleic Acid)
IBA
04/2011 - 02/2003
2
Azacitidine (5 Azacytidine)
FDA Link
04/2011 - 02/2009
2
liposomal doxorubicin (Doxil)
FDA Link
03/2010 - 08/2007
2
Paclitaxel (Taxol)
FDA Link
Generic
03/2010 - 06/2002
2
1-dodecylpyridoxal (PLD)
IBA
03/2010 - 08/2007
2
Transferases
IBA
02/2009 - 03/2002
2
Imatinib Mesylate (Gleevec)
FDA Link
06/2006 - 04/2006
2
manumycin
IBA
10/2003 - 03/2002
2
Interleukin-12 (IL 12)
IBA
05/2003 - 12/2002
1
Tyrosine Kinase Inhibitors
IBA
11/2020
1
Gefitinib (Iressa)
FDA Link
11/2020
1
Drug Combinations
IBA
11/2020
1
ErbB Receptors (EGF Receptor)
IBA
11/2020
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2014
1
Bromides
IBA
01/2013
1
diphenyl (biphenyl)
IBA
01/2013
1
Histone Deacetylase Inhibitors
IBA
01/2013
1
Histone Deacetylases (Histone Deacetylase)
IBA
01/2013
1
tozasertib
IBA
09/2012
1
perifosine
IBA
07/2012
1
thiamine triphosphorate (TTP)
IBA
06/2012
1
Cyclin G1
IBA
10/2009
1
Cyclin B1
IBA
10/2009
1
3- (4,5- dimethyl- 2- thiazolyl)- 2,5- diphenyl- 2H- tetrazolium bromide
IBA
02/2009
1
Deoxyuridine
IBA
02/2009
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
02/2009
1
Aurora Kinase B
IBA
11/2008
1
Aurora Kinase A
IBA
11/2008
1
Chondroitin
IBA
10/2008
1
Polysaccharides (Glycans)
IBA
10/2008
1
diammine dicarboxylic acid platinum
IBA
10/2008
1
Aspartic Acid (Aspartate)
FDA Link
10/2008
1
Platinum Compounds (Compounds, Platinum)
IBA
10/2008
1
Letrozole (Femara)
FDA Link
Generic
07/2008
1
Estrogen Receptors
IBA
07/2008
1
Phosphotransferases (Kinase)
IBA
06/2006
1
Cyclins
IBA
05/2006
1
Cyclin E
IBA
05/2006
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
05/2006
1
Indicators and Reagents (Reagents)
IBA
05/2006
1
Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
IBA
04/2006
1
Thrombin Receptors (Thrombin Receptor)
IBA
06/2005
1
Fibrinogen (Factor I)
FDA Link
06/2005
1
Fibrin
IBA
06/2005
1
Factor XIII (Coagulation Factor XIII)
IBA
06/2005
1
Factor XII (Hageman Factor)
IBA
06/2005
1
Factor XI (Plasma Thromboplastin Antecedent)
IBA
06/2005
1
Factor X (Stuart Factor)
IBA
06/2005
1
Factor VII (Proconvertin)
IBA
06/2005
1
Prothrombin (Factor II)
IBA
06/2005
1
Thrombin
FDA Link
06/2005
1
Thromboplastin (Tissue Factor)
IBA
06/2005
1
Endothelial Protein C Receptor
IBA
06/2005
1
Blood Coagulation Factors (Coagulation Factor)
IBA
06/2005
Therapy/Procedure
17
Therapeutics
11/2020 - 03/2002
10
Drug Therapy (Chemotherapy)
09/2012 - 06/2002
3
Aftercare (After-Treatment)
11/2020 - 03/2002
1
Radiotherapy
01/2014
1
Neoadjuvant Therapy
07/2009
1
Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2008
1
Drug Tapering
04/2006